SCHEMBL7301094

SCHEMBL7301094

CCN(CC)CCOc1ccc(-c2noc(C)n2)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACACB O00763 1/20 0.51
ACACA Q13085 1/20 0.51
AOC3 Q16853 2/20 0.50
EBP Q15125 1/20 0.50
SIGMAR1 Q99720 1/20 0.50
ESR1 P03372 2/20 0.49
S1PR1 P21453 1/20 0.49
S1PR3 Q99500 1/20 0.49
MCHR1 Q99705 2/20 0.49
ACHE P22303 1/20 0.48
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.47
NFKB1 P19838 1/20 0.47
RAB9A P51151 1/20 0.47
NFKB2 Q00653 1/20 0.47
RELA Q04206 1/20 0.47
KDR P35968 1/20 0.47
PTPN1 P18031 1/20 0.46
HTR1A P08908 1/20 0.46
HRH3 Q9Y5N1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26027547 0.84 ACACB (0.61) ACACBACACAAOC3S1PR1S1PR3
SCHEMBL7294501 0.84 ACACB (0.69) ACACBACACAAOC3S1PR1S1PR3
SCHEMBL7295310 0.84 ACACB (0.52) ACACBACACAAOC3S1PR1S1PR3
SCHEMBL7295162 0.83 NR1H4 (0.59) AOC3S1PR1S1PR3MCHR1ACHE
SCHEMBL7302028 0.79 ACACB (0.70) ACACBACACAS1PR1S1PR3RAB9A
SCHEMBL29823336 0.78 SMN1; SMN2 (0.70) S1PR1S1PR3LMNANFKB1RAB9A
SCHEMBL26022112 0.78 AOC3 (0.52) ACACBACACAAOC3S1PR1S1PR3
SCHEMBL9522122 0.76 AOC3 (0.50) ACACBACACAAOC3S1PR1S1PR3
SCHEMBL9706125 0.75 EBP (0.72) EBPSIGMAR1ESR1MCHR1HRH3
SCHEMBL3505092 0.75 L3MBTL1 (0.55) ACACBACACAAOC3S1PR1S1PR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0504574-B1 1,2,4-Oxadiazole derivatives having monoamine oxidase B enzyme-inhibitory activity and method for preparing same WAKAMOTO PHARMA CO LTD (JP) 1996-02-28 EP claimed
EP-0504574-B1 1,2,4-Oxadiazole derivatives having monoamine oxidase B enzyme-inhibitory activity and method for preparing same WAKAMOTO PHARMA CO LTD (JP) 1996-02-28 EP disclosed